TF
GSK icon

Tompkins Financial’s GSK GSK Stock Holding History

Tompkins Financial’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.24K Hold
100
– – ﹤0.01% 492
2026
Q1 		$5.52K Hold
100
– – ﹤0.01% 485
2025
Q4 		$4.9K Hold
100
– – ﹤0.01% 485
2025
Q3 		$4.32K Hold
100
– – ﹤0.01% 483
2025
Q2 		$3.84K Hold
100
– – ﹤0.01% 482
2025
Q1 		$3.87K Hold
100
– – ﹤0.01% 498
2024
Q4 		$3.38K Sell
100
-1,040
-91% -$37.4K ﹤0.01% 479
2024
Q3 		$46.6K Hold
1,140
– – ﹤0.01% 347
2024
Q2 		$43.9K Hold
1,140
– – ﹤0.01% 357
2024
Q1 		$48.9K Hold
1,140
– – 0.01% 352
2023
Q4 		$42.2K Hold
1,140
– – 0.01% 357
2023
Q3 		$41.3K Sell
1,140
-1,884
-62% -$66.9K 0.01% 334
2023
Q2 		$108K Hold
3,024
– – 0.02% 250
2023
Q1 		$108K Hold
3,024
– – 0.02% 250
2022
Q4 		$107K Buy
+3,024
New +$101K 0.02% 249
2022
Q3 		– Sell
-3,164
Closed -$172K – 600
2022
Q2 		$172K Hold
3,164
– – 0.03% 196
2022
Q1 		$173K Buy
3,164
+1,884
+147% +$102K 0.02% 212
2021
Q4 		$71K Hold
1,280
– – 0.01% 200
2021
Q3 		$61K Buy
+1,280
New +$64.3K 0.01% 212
2021
Q1 		$57K Hold
1,280
– – 0.01% 243
2020
Q4 		$59K Sell
1,280
-240
-16% -$11K 0.01% 223
2020
Q3 		$71K Hold
1,520
– – 0.01% 208
2020
Q2 		$78K Sell
1,520
-80
-5% -$4.1K 0.02% 198
2020
Q1 		$76K Buy
1,600
+240
+18% +$12.8K 0.02% 200
2019
Q4 		$80K Buy
1,360
+1,040
+325% +$57.9K 0.01% 221
2019
Q3 		$17K Sell
320
-258
-45% -$13.3K ﹤0.01% 300
2019
Q2 		$29K Hold
578
– – 0.01% 274
2019
Q1 		$30K Buy
578
+80
+16% +$4K 0.01% 275
2018
Q4 		$24K Hold
498
– – 0.01% 287
2018
Q3 		$25K Hold
498
– – 0.01% 306
2018
Q2 		$25K Buy
+498
New +$25.1K 0.01% 320
2017
Q3 		– Sell
-360
Closed -$19K – 418
2017
Q2 		$19K Buy
360
+240
+200% +$12.8K ﹤0.01% 283
2017
Q1 		$6K Sell
120
-120
-50% -$6.09K ﹤0.01% 327
2016
Q4 		$12K Hold
240
– – ﹤0.01% 308
2016
Q3 		$13K Hold
240
– – ﹤0.01% 308
2016
Q2 		$13K Hold
240
– – ﹤0.01% 369
2016
Q1 		$12K Sell
240
-240
-50% -$12K ﹤0.01% 364
2015
Q4 		$24K Hold
480
– – 0.01% 351
2015
Q3 		$23K Hold
480
– – 0.01% 359
2015
Q2 		$25K Sell
480
-1,174
-71% -$66.1K 0.01% 355
2015
Q1 		$95K Buy
1,654
+400
+32% +$22.9K 0.02% 211
2014
Q4 		$67K Sell
1,254
-192
-13% -$10.7K 0.02% 236
2014
Q3 		$83K Sell
1,446
-798
-36% -$48.9K 0.02% 206
2014
Q2 		$150K Hold
2,244
– – 0.04% 176
2014
Q1 		$149K Hold
2,244
– – 0.04% 175
2013
Q4 		$149K Buy
2,244
+157
+8% +$10.2K 0.04% 170
2013
Q3 		$131K Buy
2,087
+1,047
+101% +$67.4K 0.04% 170
2013
Q2 		$65K Buy
+1,040
New +$66K 0.02% 206

Other funds holding GSK

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
KFP
Keystone Financial Planning Cleveland, Ohio $388M AUM 16.66% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
GC
Grimes & Company Westborough, Massachusetts $4.62B AUM 29.71% 1-Year Est. Return
BB
Bell Bank Fargo, North Dakota $2.62B AUM 23.93% 1-Year Est. Return
KIC
Keating Investment Counselors Delray Beach, Florida $364M AUM 22.11% 1-Year Est. Return
GHAM
Gilman Hill Asset Management New Canaan, Connecticut $731M AUM 19.41% 1-Year Est. Return
AWAG
ARS Wealth Advisors Group St. Petersburg, Florida $1.28B AUM 24.51% 1-Year Est. Return
HAI
Hennessy Advisors Inc Novato, California $3.13B AUM 77.26% 1-Year Est. Return

Tompkins Financial's GSK Position: Q2 2026 in Review

Tompkins Financial held its GSK (GSK) position steady in Q2 2026 at 100 shares worth $5.24K. The position accounts for ﹤0.01% of the portfolio, ranked #492.

Tompkins Financial first reported a position in GSK in Q2 2013 and has held it in 48 quarters since. The position peaked at $173K in Q1 2022. 161 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Tompkins Financial held 100 shares of GSK worth $5.24K as of Q2 2026.
  • Tompkins Financial left its GSK share count unchanged in Q2 2026.
  • GSK made up ﹤0.01% of Tompkins Financial's portfolio in Q2 2026, its #492 holding.
  • Tompkins Financial first reported a position in GSK in Q2 2013 and has held it in 48 quarters since.
  • Tompkins Financial's GSK position peaked at $173K in Q1 2022.
  • 161 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Tompkins Financial's 13F filing for Q2 2026, filed 15 Jul 2026.